For: | Chen W, Cai MY, Wei DP, Wang X. Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J Gastroenterol 2005; 11(21): 3297-3299 [PMID: 15929187 DOI: 10.3748/wjg.v11.i21.3297] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i21/3297.htm |
Number | Citing Articles |
1 |
Alexandra Kirner, Andrea Mayer-Mokler, Carsten Reinhardt. IMA901: A multi-peptide cancer vaccine for treatment of renal cell cancer. Human Vaccines & Immunotherapeutics 2014; 10(11): 3179 doi: 10.4161/21645515.2014.983857
|
2 |
Yuqing Shen, Mei Xia, Jianqiong Zhang, Lianhong Xu, Jin Yang, Aiqin Chen, Fengqin Miao, Soldano Ferrone, Wei Xie. IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells. Molecular Immunology 2009; 46(10): 2045 doi: 10.1016/j.molimm.2009.03.001
|
3 |
Min Chen, Guang-Bo Wu, Shan Hua, Zhi-Feng Zhao, Hong-Jie Li, Meng Luo. Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.907859
|
4 |
Susan C. Tilton, Lena G. Gerwick, Jerry D. Hendricks, Caprice S. Rosato, Graham Corley-Smith, Scott A. Givan, George S. Bailey, Christopher J. Bayne, David E. Williams. Use of a Rainbow Trout Oligonucleotide Microarray to Determine Transcriptional Patterns in Aflatoxin B1-Induced Hepatocellular Carcinoma Compared to Adjacent Liver. Toxicological Sciences 2005; 88(2): 319 doi: 10.1093/toxsci/kfi309
|
5 |
N. Kumar, S. I. Khakoo. Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy. HLA 2018; 92(1): 3 doi: 10.1111/tan.13275
|
6 |
Wei Mi, Wei Jia, Zhaobin Zheng, Jinglan Wang, Yun Cai, Wantao Ying, Xiaohong Qian. Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification. Glycoconjugate Journal 2012; 29(5-6): 411 doi: 10.1007/s10719-012-9420-3
|